Sidoti & Co. analyst Anja Soderstrom downgrades Sanmina (NASDAQ:SANM) from Buy to Neutral.
Jaguar Health Enters Exclusive Crofelemer Revenue Sharing License And Commercialization Agreement With Quadri Pharmaceuticals Store For Rare Intestinal Failure Diseases In Middle East Markets
Quadri Pharma will cover 50% of the costs of development activity up to a capped dollar contributionJaguar to host virtual educational webinar on intestinal failure with leading gastroenterologists and nutrition experts
